PPT-Analysis of Multiple End Points in Clinical trials
Author : roberts | Published Date : 2022-06-18
By Trusha Patel and Sirisha Davuluri An efficient method for accommodating potentially underpowered primary endpoints By Jianjun David Li and Devan V Mehrotra
Presentation Embed Code
Download Presentation
Download Presentation The PPT/PDF document "Analysis of Multiple End Points in Clini..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Analysis of Multiple End Points in Clinical trials: Transcript
By Trusha Patel and Sirisha Davuluri An efficient method for accommodating potentially underpowered primary endpoints By Jianjun David Li and Devan V Mehrotra Article Details. Cynthia M. Otto, DVM, PhD DACVECC. Associate Professor of Critical Care. What is a clinical trial?. A prospective evaluation in which the factor of interest is controlled by the investigator. RANDOMIZATION. Director of Research. Royal London Hospital for Integrated Medicine. Member, WHO expert panel on Traditional & Complementary Medicine . Member, Advisory and Editorial Board, Cochrane Collaboration . Susan S. . Ellenberg. , Ph.D.. University of Pennsylvania. SCT/ICTMC Joint Meeting. Liverpool, UK. May 8, 2017. CLINICAL TRIALS TIMELINE. 1948: First randomized clinical trials of modern era. 1962: Amendments to U.S. Food, Drug and Cosmetic Act requiring demonstration of efficacy as well as safety. CLINICAL TRIALS FOR NON-STATISTICIANS. Presented on November 14, 2012 by:. Paul Wakim, PhD. Abigail G. Matthews, PhD. Clinical Trials Network. National . Institute on Drug Abuse . ─. National Institutes of Health . Back to the future? . Jeremy Grimshaw. Senior Scientist and . professor . Canada . Research Chair in Health Knowledge Transfer and Uptake. @. GrimshawJeremy. jgrimshaw@ohri.ca. 9. TH. MAY 2017. Foundational paper. Name. Institutional Affiliation. In modern society, drug companies face challenges in conducting new clinical . trials (. Biehl. , 2006. ).. The amount of drugs entering global market has reduced. . Cost of clinical trials have escalated, R&D productivity . Virginia A. Caine, M.D.. Associate Professor of Medicine. Division of Infectious Diseases. Indiana University School of Medicine. Director, Marion County Public Health Department. Indianapolis, Indiana. Ashley E. Ross MD PhD. Executive Medical Director. Mary Crowley Cancer Research Centers. NASPCC Annual Meeting 2019. Objectives. Define GCP (Good Clinical Practice) and its applications for patients and research.. Page 53 of 60 Ralf‐Dieter Hilgers*, Franz KönigDepartment of Medical Statistics, RWTH Universit Aachen, Pauwelstr 30, D‐ 52074 Aachen, Germany Dr. RalfDieter Hilgers, Department of Medical Statis Professor Julia . Brown. Leeds Institute of Clinical Trials Research, University of Leeds. Introduction. First clinical trial in 1747, James Lind. Clinical trials are gold standard for the evaluation of new treatments/interventions in health care . Primer on Sequential Design Methods . and Design Choices. Ronan Fitzpatrick. Lead Statistician. nQuery. Webinar. Host. Agenda. Sequential Design Overview. Issues in Sequential Design. Group Sequential Design. Helen Hill. Senior Regional Advisor Clinical Trials . hhill. @liv.ac.uk. www.ctrc.org.uk. . Specialist. . units . to . design, conduct, analyse and publish clinical trials and other well-designed studies. . Covered in this presentation. Basic information about clinical trials. Information about finding a clinical trial. Information about participating in or leaving a clinical trial . Vision. Mission. Make Ontario a preferred location for global clinical trials, while maintaining the highest ethical standards.. Tim Morris. MRC Clinical Trials Unit at UCL. 14 May 2018 | International Clinical Trials Day. Re-randomisation design. Definition. :. Patients . who have previously participated . may . be re-entered into a .
Download Document
Here is the link to download the presentation.
"Analysis of Multiple End Points in Clinical trials"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.
Related Documents